Diabetes decisions — 2025

The Veteran was granted a 70 percent initial disability rating for PTSD effective December 2, 2021, but the claim for an increased rating in excess of 70 percent was denied. The appeal also included claims for service connection and ratings for various conditions, some of which were granted while others were remanded.

The Board granted service connection for multiple conditions, including an acquired psychiatric disorder, sleep apnea, hypertension, and various musculoskeletal and skin disabilities.

The Board granted service connection for Type II diabetes mellitus, finding that it is secondary to the Veteran's service-connected unspecified depressive disorder.

The Board remands the claims for service connection for diabetes mellitus type II and hypertension, to include as secondary to left orchiectomy, for further development in accordance with the PACT Act.

The Board granted service connection for diabetes mellitus, type II, a blood disorder (chronic anemia), and a respiratory disability (COPD). It also granted entitlement to TDIU prior to June 2, 2023, and SMC based on housebound status from November 2, 2024.

The Board remands the claims for service connection for hypertension and diabetes mellitus to obtain further medical opinions regarding their potential relationship to toxic exposures during active service.

The Board granted service connection for diabetes mellitus, type II, based on the Veteran's exposure to herbicide agents during his active duty in Subic Bay, Philippines.

The Board granted service connection for panic disorder, OSA, and hypertension as secondary to a service-connected condition. The claim for diabetes mellitus was denied.

The Board denied an initial increased rating for diabetes mellitus type II and remanded the claims for service connection for obstructive sleep apnea, right shoulder strain with acromioclavicular joint osteoarthritis and tendinitis, cervical spine spondylosis, left knee degenerative arthritis, right knee degenerative arthritis, and thoracolumbar scoliosis and lumbar spine degenerative changes.

The Board remands the claims for service connection for various conditions, including GERD, chronic kidney disease, COPD, a heart condition, diabetes mellitus, hypertension, insomnia, and obstructive sleep apnea, as additional development is necessary to address the Veteran's exposure to toxic chemical agents during his service.

The Board remands the claims for service connection for right foot, left elbow, left hip, left ankle, and diabetes mellitus to obtain additional medical evidence.

The Board granted service connection for diabetes mellitus, type II and neuropathy of the extremities due to in-service exposure to herbicide agents. The claims for a sinus disorder and facial skin disorder were remanded.

The Board denied increased ratings for hypertension, atherosclerosis, and diabetes mellitus; granted service connection for erectile dysfunction and skin cancer; and restored the 10 percent rating for hypertension.

The Board granted service connection for the cause of the Veteran's death, finding that Type II diabetes mellitus and hypertension, which are presumed to have resulted from herbicide exposure during service, contributed substantially to his demise.

The Board remands the claims for service connection for diabetes mellitus and sleep apnea to obtain a TERA opinion due to the Veteran's participation in a toxic exposure risk activity during his service in the Southwest Asia theater of operations.

The Board denied increased ratings for bilateral hearing loss, right inguinal hernia, non allergic rhinitis, sinusitis, and irritable bowel syndrome (IBS), while granting service connection for left knee strain and left leg shin splints.

The Board denied service connection for diabetes type II and kidney stones as the evidence did not support a finding that these conditions began during active service, manifested within one year of service, or were otherwise related to an in-service injury, disease, or exposure.

The Board denied the veteran's claims for increased ratings for type II diabetes mellitus, diabetic peripheral neuropathy of the right lower extremity, and diabetic peripheral neuropathy of the left lower extremity.

The Board denied service connection for various conditions, including diabetes mellitus, type II, coronary artery disease, congestive heart failure, hypertension, asthma/lung disease, vision disability, bilateral plantar fasciitis, leukocytosis, kidney disease/kidney stones, enlarged prostate, sleep apnea, rheumatoid arthritis, lumbar spine disability, right ankle disability, and left ankle disability.

The Board denied service connection for an inguinal hernia and remanded the claims for diabetes mellitus type II, hypertension, a skin condition, suspicious nevus, and chronic obstructive pulmonary disease.